
Cadila Healthcare Limited has informed the Exchange regarding a press release dated November 23, 2021, titled "Zydus develops new treatment for patients suffering from Chronic Kidney Disease (CKD), submits first New Drug Application (NDA) to DCGI".
Filed with NSE ·

Cadila Healthcare Limited has informed the Exchange regarding a press release dated November 23, 2021, titled "Zydus develops new treatment for patients suffering from Chronic Kidney Disease (CKD), submits first New Drug Application (NDA) to DCGI".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences